Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

It’s time to measure outcomes

August 1, 2017 | Data, Medical Communications, medical education 

Lucid launch their new metrics platform

- PMLiVE

With shrinking budgets and shorter timelines, pharmaceutical companies are keen to invest their assets smartly in medical education programmes that will guarantee their desired outcomes. Medical communications have aimed to keep pace with this development through evaluation forms and post-event surveys. However, these usually measure the level of audience satisfaction, rather than our actual progress towards our ultimate goal. In the latest issue of PME, Dennis O’Brien (Lucid Co-founder and CEO) discusses the need to demonstrate that medical education programmes are truly achieving what they promise.

“It’s time to think of new ways of measuring effectiveness, particularly relating to outcomes,” says Dennis. He comments on the frequent use of patient information leaflets: “If we haven’t got evidence that it improves patient outcomes, then we shouldn’t be doing it. Let’s invest our time where it matters.”

Dennis explains Lucid’s new solution to this challenge of measuring outcomes: “Our latest methodology at Lucid is a metrics platform. It provides a strategic approach to education that starts by defining our WHY – the outcomes we want to achieve. We then look at what behaviours we need in our audience to get us there. Where once we thought it was only our medicines that could improve outcomes, we can now demonstrate that it’s our services and our communications that make a difference.”

To read Dennis’ full article, click the following link: http://www.pmlive.com/__data/assets/pdf_file/0004/1199893/45_Lucid_TL.pdf

This content was provided by Lucid Group Communications Limited

Company Details

- PMLiVE

Lucid Group Communications Limited

Email
Website

 Latest Content from  Lucid Group Communications Limited 

A summer meeting full of magical moments

In their day-to-day, everybody at Lucid Group strives to develop outstanding medical education programmes to improve patient outcomes. Over the summer, however, they like to take some time to turn...

Sir Henry presents Queen’s Award for Enterprise to Lucid Group

On 13 July, Lord Lieutenant Sir Henry presented Lucid Group with the Queen’s Award for Enterprise in International Trade. This award recognises UK-based businesses that have achieved outstanding growth overseas...

Lucid Group’s winning formula is recognised at Communiqué 2017

Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications...

Lucid Partners grows its medical writing team

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

All five of Lucid’s entries reach the shortlist for Communiqué 2017

Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...

Your career starts here

When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...

Are you suffering from templatitis?

At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...

It’s time to shine for Lucid’s rare disease team

No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...

Focus on Rare Diseases

As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.